Biotech stocks drop 10% due to FDA uncertainty

Investor confidence in biotech firms will decline as the FDA leadership crisis raises concerns over delayed approvals and regulatory unpredictability. Major biotech indices will underperform the broader market by at least 10% within 6 months.

Implied probability (Yes)

68%